FAQ

Vitamin K Antagonist [EPC]

Known as: Vitamin K Antagonist 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
012320112017

Related topics

Related topics

2 relations
Treatment with Vitamin K antagonistVitamin K antagonists

Related mentions per year

Related mentions per year

2002-2018
20002005201020152020
Vitamin K Antagonist [EPC]
Vitamin K antagonists
Treatment with Vitamin K antagonist

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation.
Effective stroke prevention in patients with atrial fibrillation (AF) means using oral anticoagulation (OAC) therapy, which… (More)
Is this relevant?
2015
2015
Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) study was conducted to estimate event rates in…
Atrial fibrillation (AF) is associated with a 4to 5-fold increase in the risk of experiencing stroke. Because of the mortality… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
BACKGROUND AND PURPOSE Although recommended by guidelines, the benefits of treating patients with atrial fibrillation with a low… (More)
Is this relevant?
2015
2015
Comparison of Medical Costs of Patients With Atrial Fibrillation Unsuitable for Warfarin Treatment With Apixaban or Aspirin Based on AVERROES Trial.
BACKGROUND The AVERROES trial name is the following: The Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial… (More)
Is this relevant?
2014
2014
Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
BACKGROUND AND PURPOSE The main objective of the present analysis was to assess the effect of treatment with aspirin compared… (More)
  • table II
Is this relevant?
Review
2013
Review
2013
Stroke patients with suspected atrial fibrillation should be started on anticoagulation pending the results of long-term cardiac monitoring.
The fact that the patient experienced intermittent palpitations, has an infarct on imaging suggesting an embolic pattern, and has… (More)
Is this relevant?
2012
2012
Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
BACKGROUND Apixaban is superior to aspirin for the prevention of stroke in patients with atrial fibrillation. Apixaban is… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2012
2012
Letter by Lai and Chan regarding article, "Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian…
 
Is this relevant?
Review
2011
Review
2011
Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
The objective of this review is to summarize data from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Vascular Medicine Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation
Background—Vitamin K antagonist (VKA) therapy is increasingly being used for the prevention of venous thromboembolism and stroke… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 6
Is this relevant?